Literature DB >> 8599409

Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment.

J A Frazier1, J N Giedd, D Kaysen, K Albus, S Hamburger, J Alaghband-Rad, M C Lenane, K McKenna, A Breier, J L Rapoport.   

Abstract

OBJECTIVE: The effect of clozapine on striatal morphology was examined in adolescents with childhood-onset schizophrenia.
METHOD: Eight adolescent patients with onset of psychosis before age 12 and eight matched comparison subjects had initial and 2-year follow-up brain magnetic resonance imaging scans. Basal ganglia and lateral ventricle volumes were measured. The patients were on a clozapine regimen during the 2-year interim.
RESULTS: Caudate volume was larger in the patients at the initial scanning, decreased in the patients between scans, and did not differ significantly between the patients and the comparison subjects at the second scanning.
CONCLUSIONS: Caudate enlargement in patients with childhood-onset schizophrenia who are taking typical neuroleptics appears to be secondary to medication exposure. Rescanning to examine basal ganglia morphology is indicated for these patients when they are taking an atypical neuroleptic.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8599409     DOI: 10.1176/ajp.153.4.564

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  28 in total

Review 1.  Neuroimaging in child and adolescent psychiatric disorders.

Authors:  P J Santosh
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

2.  Combined stimulant and antipsychotic treatment in adolescents with attention-deficit/hyperactivity disorder: a cross-sectional observational structural MRI study.

Authors:  L J S Schweren; C A Hartman; M P Zwiers; D J Heslenfeld; D van der Meer; B Franke; J Oosterlaan; J K Buitelaar; P J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-11-14       Impact factor: 4.785

3.  First- and second-generation antipsychotic drug treatment and subcortical brain morphology in schizophrenia.

Authors:  Kjetil N Jørgensen; Ragnar Nesvåg; Sindre Gunleiksrud; Andrea Raballo; Erik G Jönsson; Ingrid Agartz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-11-07       Impact factor: 5.270

Review 4.  Predictors and markers of clozapine response.

Authors:  Carmen Chung; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

Review 5.  Antipsychotic drugs for first-episode schizophrenia: a comparative review.

Authors:  Kayvon Salimi; L Fredrik Jarskog; Jeffrey A Lieberman
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

6.  Identifying global anatomical differences: deformation-based morphometry.

Authors:  J Ashburner; C Hutton; R Frackowiak; I Johnsrude; C Price; K Friston
Journal:  Hum Brain Mapp       Date:  1998       Impact factor: 5.038

7.  Psychotropic Medications and Their Effect on Brain Volumes in Childhood Psychopathology.

Authors:  Natasha Marrus; Marisa Bell; Joan L Luby
Journal:  Child Adolesc Psychopharmacol News       Date:  2014-04

8.  Striatal shape abnormalities as novel neurodevelopmental endophenotypes in schizophrenia: a longitudinal study.

Authors:  M Mallar Chakravarty; Judith L Rapoport; Jay N Giedd; Armin Raznahan; Philip Shaw; D Louis Collins; Jason P Lerch; Nitin Gogtay
Journal:  Hum Brain Mapp       Date:  2014-12-11       Impact factor: 5.038

9.  Subcortical differences among youths with attention-deficit/hyperactivity disorder compared to those with bipolar disorder with and without attention-deficit/hyperactivity disorder.

Authors:  Melissa Lopez-Larson; Emily S Michael; Janine E Terry; Janis L Breeze; Steven M Hodge; Lena Tang; David N Kennedy; Constance M Moore; Nikos Makris; Verne S Caviness; Jean A Frazier
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

Review 10.  What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia.

Authors:  Hilleke E Hulshoff Pol; René S Kahn
Journal:  Schizophr Bull       Date:  2008-02-17       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.